DOSING FOR TREATMENT WITH ANTI-CD20/ANTI-CD3 BISPECIFIC ANTIBODIES
The present invention relates to the treatment of subjects having CD20-positive cell proliferative disorders (e.g., B cell proliferative disorders, such as non-Hodgkin's lymphomas). More specifically, the invention pertains to the treatment of subjects having a B cell proliferative disorder by...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English Spanish |
Published |
25.05.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!